TL;DR

Before you orderOffer from Amazon

Get oils, diffusers and self-care delivered free with Prime

• Fast, free delivery on millions of items
• Prime Video, Amazon Music and more included
• Member-only deals all year

Start your free Prime trial →Free trial for eligible customers · Cancel anytime

As an affiliate, we earn on qualifying purchases.Hide

The supplied research points to cognitive behavioral therapy for insomnia (CBT-I) as the best-supported non-drug option for sleep problems during menopause. Exercise may also help, while evidence for melatonin and valerian is limited; the right response depends partly on why someone is waking.

Research cited in a review of menopause-related sleep problems supports cognitive behavioral therapy for insomnia (CBT-I) more strongly than supplements such as melatonin or valerian, while pointing to different causes of nighttime waking that may call for different responses. The evidence does not establish one natural remedy that works for everyone, and persistent sleep disruption can warrant assessment for conditions such as sleep apnea.

A randomized trial involving 106 midlife women with frequent hot flashes and insomnia found that telephone-delivered CBT-I improved insomnia severity by about 5.2 points more than menopause education at eight weeks. The improvement was still present at 24 weeks, according to the study summary. CBT-I is a structured treatment that works on sleep habits and the thoughts and behaviors that can keep insomnia going; it is not simply advice to maintain a dark, quiet bedroom.

Guidance from the American College of Physicians recommends CBT-I as initial treatment for adults with chronic insomnia. That recommendation is for adults generally, not specifically for menopause. The American Academy of Sleep Medicine recommends multicomponent CBT-I and advises against relying on sleep hygiene alone as a treatment for chronic insomnia.

The evidence for popular supplements is less persuasive in the cited material. Across four randomized trials in menopausal women, melatonin did not produce a statistically significant improvement in sleep quality; that result leaves its effect uncertain rather than proving it cannot help. A 2024 umbrella review of eight systematic reviews judged evidence for valerian weak or inconclusive and found no evidence of efficacy for insomnia. These findings do not establish that every product or individual experience is identical, but they do not support treating either supplement as a proven solution.

Choosing Treatment by the Wake-Up Pattern

Sleep loss during menopause can affect concentration, mood and daily functioning, but treating every night waking as the same problem may lead people toward options that do not address its cause. The research summary distinguishes heat-related waking, possible breathing-related disruption and learned patterns of wakefulness. These are an organizing framework, not a formal clinical classification, and more than one may be present in the same person.

That distinction matters because a sleep strategy aimed at hot flashes may not address obstructive sleep apnea, while a supplement may not change a cycle of lying awake and becoming anxious about sleep. The available evidence makes CBT-I a better-supported starting point for chronic insomnia than an unranked list of over-the-counter remedies. It also gives readers a reason to discuss recurring symptoms with a health professional rather than assuming every disrupted night is simply part of menopause.

How Menopause Can Disrupt Sleep

The Study of Women’s Health Across the Nation followed 3,045 women aged 42 to 52 at enrollment. In analyses of the cohort, the odds of trouble falling asleep and staying asleep rose across the menopausal transition. A secondary analysis reported self-described insomnia symptoms at least three times a week in 31% of women in early perimenopause in year one, rising to 39% by year ten; among women in late perimenopause, the figures rose from 32% to 48%. These are reported symptoms, not rates of clinically diagnosed insomnia, and the figures vary by stage and year.

Hot flashes are one possible source of interruption. In a study of 168 midlife women monitored with actigraphy, 78% of objectively recorded nighttime hot flashes coincided with a wake episode. The association does not prove that a flash caused every awakening. Other research found the adjusted apnea-hypopnea index—a measure of breathing events—was about 31% higher after menopause than before it in the Sleep in Midlife Women Study. That measure is not a count of new sleep apnea diagnoses.

“CBT-I is recommended as the initial treatment for adults with chronic insomnia.”

— American College of Physicians

What the Research Cannot Settle

The findings do not show that CBT-I resolves every menopause-related sleep problem or identify which approach will work for a particular person. The cited trial was relatively small, and the supplied material does not give enough detail to compare CBT-I with every other treatment or to assess differences across participants. It also describes the ranking of CBT-I, exercise and supplements as the review’s own evidence-based ordering, not as a formal treatment guideline.

For melatonin, a result that was not statistically significant is not proof of no effect; it means the cited trials did not establish a reliable improvement in sleep quality. The valerian review likewise describes weak or inconclusive evidence. The material gives no specific exercise protocol or estimate of its effect, so exercise should not be presented as equivalent to CBT-I. It also does not establish that waking is caused by menopause in every case. Symptoms such as ongoing fatigue, insomnia or low mood can overlap with sleep apnea and other conditions, and the source does not provide an individual diagnostic assessment.

Discuss Ongoing Sleep Disruption

People with persistent insomnia can ask a clinician about CBT-I, including therapist-led or guided digital options, and whether their symptoms call for evaluation of hot flashes, breathing-related problems or another cause. The cited research does not announce a new trial or upcoming policy change; the next step for individuals is to match care to their symptoms rather than assume a supplement will address every type of waking.

Anyone considering a supplement should discuss its use with a qualified health professional, particularly when taking other medicines or managing a health condition. The evidence summarized here does not establish a dose or guarantee safety for an individual. Further research would help clarify which menopause-related sleep patterns respond to specific approaches and how exercise compares with structured CBT-I.

Key Questions

Which non-drug approach has the strongest evidence here?

CBT-I has the strongest support in the research described. A trial in 106 midlife women with frequent hot flashes and insomnia found greater improvement than menopause education at eight weeks, with gains still present at 24 weeks.

Does the research show that melatonin works for menopause sleep problems?

Not conclusively. Across four randomized trials in menopausal women, the effect on sleep quality was not statistically significant. This leaves the effect uncertain; it does not prove melatonin never helps.

What does the evidence say about valerian?

A 2024 umbrella review of eight systematic reviews judged the evidence for valerian weak or inconclusive and found no evidence of efficacy for insomnia in the reviews assessed.

Can sleep problems during menopause have causes other than hot flashes?

Yes. The research discussed includes possible breathing-related sleep disruption as well as learned wakefulness that continues after hot flashes ease. The patterns can overlap, and the framework is not a diagnostic classification.

When should someone seek professional advice?

Consider speaking with a health professional when sleep disruption is persistent, affects daily life, or comes with ongoing fatigue or low mood. A clinician can discuss CBT-I and assess whether another condition, including sleep apnea, may be contributing.

Source: rss